These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 33738419)

  • 1. Progression of electrocardiogram changes in an untreated fabry disease: a case report.
    Mattig I; Canaan-Kühl S; Tillmanns C; Knebel F
    Eur Heart J Case Rep; 2021 Feb; 5(2):ytab045. PubMed ID: 33738419
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The myocardial phenotype of Fabry disease pre-hypertrophy and pre-detectable storage.
    Augusto JB; Johner N; Shah D; Nordin S; Knott KD; Rosmini S; Lau C; Alfarih M; Hughes R; Seraphim A; Vijapurapu R; Bhuva A; Lin L; Ojrzyńska N; Geberhiwot T; Captur G; Ramaswami U; Steeds RP; Kozor R; Hughes D; Moon JC; Namdar M
    Eur Heart J Cardiovasc Imaging; 2021 Jun; 22(7):790-799. PubMed ID: 32514567
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systolic and diastolic function assessment in fabry disease patients using speckle-tracking imaging and comparison with conventional echocardiographic measurements.
    Shanks M; Thompson RB; Paterson ID; Putko B; Khan A; Chan A; Becher H; Oudit GY
    J Am Soc Echocardiogr; 2013 Dec; 26(12):1407-14. PubMed ID: 24125876
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Value of electrocardiogram in the differentiation of hypertensive heart disease, hypertrophic cardiomyopathy, aortic stenosis, amyloidosis, and Fabry disease.
    Namdar M; Steffel J; Jetzer S; Schmied C; Hürlimann D; Camici GG; Bayrak F; Ricciardi D; Rao JY; de Asmundis C; Chierchia GB; Sarkozy A; Lüscher TF; Jenni R; Duru F; Brugada P
    Am J Cardiol; 2012 Feb; 109(4):587-93. PubMed ID: 22105784
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Uncertain diagnosis of Fabry disease: consensus recommendation on diagnosis in adults with left ventricular hypertrophy and genetic variants of unknown significance.
    Smid BE; van der Tol L; Cecchi F; Elliott PM; Hughes DA; Linthorst GE; Timmermans J; Weidemann F; West ML; Biegstraaten M; Lekanne Deprez RH; Florquin S; Postema PG; Tomberli B; van der Wal AC; van den Bergh Weerman MA; Hollak CE
    Int J Cardiol; 2014 Dec; 177(2):400-8. PubMed ID: 25442977
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fabry disease with acute myocardial infarction, left ventricular thrombosis, and pericardial effusion: A case report.
    Zhou S; Wang X; Xu H; Li J; Zhang L; Li H
    Medicine (Baltimore); 2022 May; 101(21):e29427. PubMed ID: 35623077
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanical dispersion in Fabry disease assessed with speckle tracking echocardiography.
    Cianciulli TF; Saccheri MC; Rísolo MA; Lax JA; Méndez RJ; Morita LA; Beck MA; Kazelián LR
    Echocardiography; 2020 Feb; 37(2):293-301. PubMed ID: 31957094
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fabry disease and its cardiac involvement.
    Kubo T
    J Gen Fam Med; 2017 Oct; 18(5):225-229. PubMed ID: 29264031
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Electrocardiographic Characteristics and Their Correlation with Echocardiographic Alterations in Fabry Disease.
    Zada M; Lo Q; Trivedi SJ; Harapoz M; Boyd AC; Devine K; Sadick N; Tchan MC; Thomas L
    J Cardiovasc Dev Dis; 2022 Jan; 9(1):. PubMed ID: 35050221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of base-to-apex circumferential strain gradient assessed by cardiovascular magnetic resonance in Fabry disease: relationship to T1 mapping, late gadolinium enhancement and hypertrophy.
    Mathur S; Dreisbach JG; Karur GR; Iwanochko RM; Morel CF; Wasim S; Nguyen ET; Wintersperger BJ; Hanneman K
    J Cardiovasc Magn Reson; 2019 Aug; 21(1):45. PubMed ID: 31366357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of Fabry disease in male patients with unexplained left ventricular hypertrophy in primary cardiology practice: prospective Fabry cardiomyopathy screening study (FACSS).
    Palecek T; Honzikova J; Poupetova H; Vlaskova H; Kuchynka P; Golan L; Magage S; Linhart A
    J Inherit Metab Dis; 2014 May; 37(3):455-60. PubMed ID: 24173410
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characteristics of the Electrocardiogram in Japanese Fabry Patients Under Long-Term Enzyme Replacement Therapy.
    Morimoto S; Nojiri A; Fukuro E; Anan I; Kawai M; Sakurai K; Kobayashi M; Kobayashi H; Ida H; Ohashi T; Shibata T; Yoshimura M; Eto Y; Hongo K
    Front Cardiovasc Med; 2020; 7():614129. PubMed ID: 33521063
    [No Abstract]   [Full Text] [Related]  

  • 13. Enzyme replacement therapy improves cardiac features and severity of Fabry disease.
    Motwani M; Banypersad S; Woolfson P; Waldek S
    Mol Genet Metab; 2012 Sep; 107(1-2):197-202. PubMed ID: 22704481
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiac magnetic resonance in Fabry disease.
    Lanzillo C; Fedele E; Martino A; Ferrazza A; Fusco A; Silvetti E; Canestrelli S; Romeo F; Canali E; De Luca L; Golia P; Crescenzi C; Stefanini M; Calò L
    Eur Heart J Suppl; 2023 May; 25(Suppl C):C200-C204. PubMed ID: 37125302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proposed Stages of Myocardial Phenotype Development in Fabry Disease.
    Nordin S; Kozor R; Medina-Menacho K; Abdel-Gadir A; Baig S; Sado DM; Lobascio I; Murphy E; Lachmann RH; Mehta A; Edwards NC; Ramaswami U; Steeds RP; Hughes D; Moon JC
    JACC Cardiovasc Imaging; 2019 Aug; 12(8 Pt 2):1673-1683. PubMed ID: 29778854
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ventricular fibrillation associated with vasospastic angina pectoris in Fabry disease: a case report.
    Kodama K; Ozawa T; Dochi K; Ueno Y
    Eur Heart J Case Rep; 2019 Dec; 3(4):1-5. PubMed ID: 32123796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Global longitudinal strain, myocardial storage and hypertrophy in Fabry disease.
    Vijapurapu R; Nordin S; Baig S; Liu B; Rosmini S; Augusto J; Tchan M; Hughes DA; Geberhiwot T; Moon JC; Steeds RP; Kozor R
    Heart; 2019 Mar; 105(6):470-476. PubMed ID: 30282640
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ventricular tachycardia: a presentation of Fabry disease case report.
    Pavlu L; Kocourkova L; Taborsky M; Petrkova J
    Eur Heart J Case Rep; 2019 Mar; 3(1):yty154. PubMed ID: 31020230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early cardiac changes in children with anderson-fabry disease.
    Havranek S; Linhart A; Urbanova Z; Ramaswami U
    JIMD Rep; 2013; 11():53-64. PubMed ID: 23546814
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of left atrial size and function in hypertrophic cardiomyopathy and in Fabry disease with left ventricular hypertrophy.
    Saccheri MC; Cianciulli TF; Challapa Licidio W; Lax JA; Beck MA; Morita LA; Gagliardi JA;
    Echocardiography; 2018 May; 35(5):643-650. PubMed ID: 29457264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.